ClinConnect ClinConnect Logo
Search / Trial NCT06424366

Approach to Dance for Autism

Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · May 16, 2024

Trial Information

Current as of July 25, 2025

Completed

Keywords

Ballet Autism Motor Recreational Children Dance

ClinConnect Summary

The "Approach to Dance for Autism" trial is studying how a recreational ballet program can help children with Autism Spectrum Disorder (ASD). The research team wants to see if this program can improve motor skills, as well as social, psychological, and behavioral skills in children aged 7 to 12 who have a confirmed diagnosis of ASD and can speak either English or Spanish. The study will include 24 participants, and all children will take part in a 12-week ballet program designed specifically for kids with ASD by a non-profit organization that has over ten years of experience in this area.

To participate, children must be between 7 and 12 years old, diagnosed with ASD, and speak English or Spanish. They should also be able to attend at least 8 out of the 12 ballet classes. The children will be divided into two groups: one will take the ballet classes while the other will wait and take them later. Throughout the study, caregivers will fill out questionnaires to help the researchers understand the impact of the ballet program. This research aims to gather valuable information that could shape future activities and treatments for children with ASD.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Confirmed diagnosis of autism spectrum disorder
  • Fluent in English or Spanish
  • Between 7-12 years old
  • Exclusion Criteria:
  • For any reason the individual appears unable to participate in study procedures per the Principal Investigator
  • Not fluent in English or Spanish
  • Unable to commit to at least 8 of the 12 scheduled intervention sessions

About Icahn School Of Medicine At Mount Sinai

The Icahn School of Medicine at Mount Sinai is a premier academic institution located in New York City, renowned for its commitment to advancing medical research, education, and patient care. As a leading sponsor of clinical trials, the institution leverages its state-of-the-art facilities and multidisciplinary expertise to drive innovative research initiatives aimed at improving health outcomes. With a focus on translational medicine, the Icahn School of Medicine collaborates with a diverse network of researchers, clinicians, and industry partners to explore novel therapies and interventions across a wide range of medical disciplines. Its rigorous scientific approach and dedication to ethical standards position it as a trusted leader in the clinical research landscape.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Alexander Kolevzon, MD

Principal Investigator

Icahn School of Medicine at Mount Sinai

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported